Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-30T19:46:35.482Z Has data issue: false hasContentIssue false
  • English
  • Français

Use of terbutaline in the treatment of complete heart block in the fetus

Published online by Cambridge University Press:  15 August 2006

Blair V. Robinson ,
José A. Ettedgui  and
Frederick S. Sherman
Blair V. Robinson
Affiliation:
University of North Carolina at Chapel Hill, NC, USA
José A. Ettedgui
Affiliation:
Children's Hospital of Pittsburgh, Pittsburgh, USA
Frederick S. Sherman
Affiliation:
Magee-Women's Hospital, Pittsburgh, PA, USA
Get access Rights & Permissions [Opens in a new window]

Abstract

Between 1989 and 2000, 21 fetuses were diagnosed with complete atrioventricular block. Seven women with fetal ventricular rates of less than 60 were given oral terbutaline, and 6 of these had an initial increase in the fetal ventricular rate. Four fetuses (57%) maintained an increased average rate of 60 beats per minute and survived. Two fetuses returned to rates below 55 and died. The final fetus, with hypertrophic cardiomyopathy, was unresponsive. Terbutaline, therefore, is initially effective in raising the fetal ventricular rate, but this effect may be transient.

Keywords

Congenitalheart blockfetalechocardiography
Type
Brief Report
Information
Cardiology in the Young , Volume 11 , Issue 6 , November 2001 , pp. 683 - 686
Copyright
2001 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)